NYSEMKT: SER
Serina Therapeutics Inc Stock Ownership - Who owns Serina Therapeutics?

Insider buying vs selling

Have Serina Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Randall MoreadithChief Scientific Officer2026-02-026,500$3.03
$19.68kSell
Randall MoreadithChief Scientific Officer2026-02-026,500$0.06
$390.00Buy
Randall MoreadithChief Scientific Officer2026-01-286,500$3.57
$23.19kSell
Randall MoreadithChief Scientific Officer2026-01-286,500$0.06
$390.00Buy
Randall MoreadithChief Scientific Officer2026-01-222,500$0.06
$150.00Buy
Randall MoreadithChief Scientific Officer2026-01-222,500$2.95
$7.38kSell
Randall MoreadithChief Scientific Officer2026-01-212,000$3.00
$6.00kSell
Randall MoreadithChief Scientific Officer2026-01-212,000$0.06
$120.00Buy
Randall MoreadithChief Scientific Officer2026-01-202,000$3.07
$6.14kSell
Randall MoreadithChief Scientific Officer2026-01-202,000$0.06
$120.00Buy

1 of 8

SER insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SER insiders and whales buy or sell their stock.

SER Shareholders

What type of owners hold Serina Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Juvenescence Ltd210.82%22,481,876$63.85MInsider
Juvenescence Us Corp154.23%16,447,500$46.71MInsider
Steven A. Ledger3.04%323,657$919.19kInsider
Vanguard Group Inc1.69%180,013$511.24kInstitution
John F. Mauldin1.17%125,000$355.00kInsider
Broadwood Capital Inc0.78%83,195$236.27kInstitution
Waverly Advisors LLC0.63%67,492$191.68kInstitution
Gregory Bailey0.63%67,243$190.97kInsider
Tacey Viegas0.55%58,610$166.45kInsider
Judith Segall0.49%52,624$149.45kInsider

1 of 3

SER vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SER1.15%98.85%Net BuyingNet Buying
SKYE2.73%97.27%Net Selling
XCUR0.58%99.42%Net SellingNet Selling
XLO38.75%61.25%Net BuyingNet Selling
PTN0.00%100.00%Net BuyingNet Selling

Serina Therapeutics Stock Ownership FAQ

Who owns Serina Therapeutics?

Serina Therapeutics (NYSEMKT: SER) is owned by 4.33% institutional shareholders, 372.02% Serina Therapeutics insiders, and 0.00% retail investors. Juvenescence Ltd is the largest individual Serina Therapeutics shareholder, owning 22.48M shares representing 210.82% of the company. Juvenescence Ltd's Serina Therapeutics shares are currently valued at $55.53M.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.